ABBV Jan 2025 200.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:24PM EDT. Market open.
| Previous close | 3.1500 |
| Open | 3.0500 |
| Bid | 2.7300 |
| Ask | 2.9800 |
| Strike | 200.00 |
| Expiry date | 2025-01-17 |
| Day's range | 2.8300 - 3.0500 |
| Contract range | N/A |
| Volume | |
| Open interest | 3.83k |
ZacksWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
Zacks4 Large Drug Stocks to Hold on to Amid Industry Challenges
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk (NVO), Merck (MRK) and AbbVie (ABBV) are worth retaining in one's portfolio.
ZacksWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
Let's look at five biotech/drug companies, MRK, SNY, BMY, GILD and ABBV, slated to release their first quarter 2024 earnings results this week.
© 2024 Yahoo. All rights reserved.